The Company has advanced this highly potent monoclonal antibody into separate Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps ... ("EEG") platform ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

Strawberry Fields REIT, Inc. (the "Company") reported today its operating results for the quarter ended September 30, 2024.FINANCIAL HIGHLIGHTS100% of contractual rents collected.On July 12, ...